883TiP MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer

Autor: Randall, L.M., O'Malley, D.M., Monk, B.J., Coleman, R.L., O'Cearbhaill, R.E., Gaillard, S., Adams, S., Cappuccini, F., Huang, M., Chon, H.S., Secord, A.A., Arora, S., Keeton, E., Gupta, D., Samnotra, V., Konstantinopoulos, P.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S646-S647
Databáze: ScienceDirect